Nav: Home

Report reveals why millions of people with osteoporosis remain undiagnosed and untreated

October 10, 2016

October 10, 2016 - Nyon, Switzerland - Approximately 80% of those who have already suffered a broken bone due to osteoporosis remain unprotected against the risk of further disabling fractures, according to a new report issued by the International Osteoporosis Foundation (IOF) in anticipation of World Osteoporosis Day.

The report finds that, despite the global threat posed by fragility fractures, and the availability of safe and cost-effective therapies that could reduce the number of fractures, gaps in care are preventing millions of at-risk individuals from being diagnosed and treated worldwide.

"This report is a necessary and urgent call to action," said co-author Professor Eugene McCloskey, Director of the MRC ARUK Centre for Integrated Research in Musculoskeletal Ageing, Metabolic Bone Centre, Northern General Hospital, Sheffield, UK.

"A 'fracture tsunami' is approaching, and the resulting human and socioeconomic burden will have an enormous impact on all countries with ageing populations. The result of fragility fractures can be profoundly debilitating, with chronic pain and disability leading to reduced mobility and quality of life. Fewer than half of seniors who survive a hip fracture will walk unaided again, and up to 20% will become residents of care homes in the year following the fracture."

The report identifies the following ten major care gaps that are preventing early assessment and treatment, and outlines possible solutions that could be implemented by national health authorities worldwide:
  • Poor case finding and management is found in regard to (1) secondary fracture prevention, (2) osteoporosis induced by medicines, (3) diseases associated with osteoporosis, and (4) primary fracture prevention for individuals at high risk of fracture;

  • Suboptimal communication and low public awareness is identified in regard to (5) the importance of staying on prescribed treatment, (6) public awareness of the serious impact of osteoporosis and fracture risk, (7) knowledge of the benefits versus the risks of osteoporosis treatment;

  • Neglect by national governments and healthcare systems: (8) impeding access and reimbursement to osteoporosis assessment and treatment, (9) failing to prioritize fragility fracture prevention in national healthcare policy;

  • Lack of epidemiological data (10) particularly in the developing world, is needed to help inform policy development. This is of special urgency given that projections indicate that the burden of fragility fractures will shift to the developing world over the next four decades.

IOF President Professor John A. Kanis added,

"The care gaps described in this report, together with their associated solutions, outline a Global Framework for tackling the devastating burden of osteoporotic fractures around the world. We urge national policymakers and healthcare professional organizations to work together to identify local gaps in the provision of best practice for the populations that they serve. One important step, among others, is the systematic implementation of Fracture Liaison Services to address the need for secondary fracture prevention within the most high risk patients."

"It is clear that the time for optimal management of bone health is now - not in 10 or 20 years' time when it will already be too late."
-end-
The report 'Gaps and Solutions in Bone Health; A Global Framework for Improvement' is authored by Professors N.C Harvey and E.V McCloskey. It can be downloaded at http://worldosteoporosisday.org/thematic-report-2016

About IOF

The International Osteoporosis Foundation (IOF) is the world's largest nongovernmental organization dedicated to the prevention, diagnosis and treatment of osteoporosis and related musculoskeletal diseases. IOF members, including leading scientific experts and 237 patient, medical and research societies in 99 locations worldwide, work together to make bone health a global health care priority. Among its many scientific, medical education, policy, and public awareness programmes, IOF leads the annual World Osteoporosis Day campaign and co-organizes the World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases. http://www.iofbonehealth.org / http://www.worldosteoporosisday.org / http://www.capturethefracture.org / @iofbonehealth

About World Osteoporosis Day

World Osteoporosis Day is observed annually on 20 October, and marks the beginning of a year-long campaign dedicated to raising global awareness of the prevention, diagnosis and treatment of osteoporosis and related musculoskeletal diseases. Led by the International Osteoporosis Foundation (IOF), it generates worldwide media attention and supports public awareness campaigns organized by 237 national osteoporosis patient and medical societies from around the world. http://www.worldosteoporosisday.org / http://www.facebook.com/worldosteoporosisday; #LoveYourBones

International Osteoporosis Foundation

Related Osteoporosis Articles:

New pharmaceutical target reverses osteoporosis in mice
Biomedical engineers at Duke University have discovered that an adenosine receptor called A2B can be pharmaceutically activated to reverse bone degradation caused by osteoporosis in mouse models of the disease.
A link between mitochondrial damage and osteoporosis
In healthy people, a tightly controlled process balances out the activity of osteoblasts, which build bone, and osteoclasts, which break it down.
Many stroke patients not screened for osteoporosis, despite known risks
Many stroke survivors have an increased risk of osteoporosis, falls or breaks when compared to healthy people.
Many postmenopausal women do not receive treatment for osteoporosis
The benefits of treating osteoporosis in postmenopausal women outweigh the perceived risks, according to a Clinical Practice Guideline issued today by the Endocrine Society.
A new 'atlas' of genetic influences on osteoporosis
A ground-breaking new study led by researchers from the Lady Davis Institute (LDI) at the Jewish General Hospital (JGH) has succeeded in compiling an atlas of genetic factors associated with estimated bone mineral density (BMD), one of the most clinically relevant factors in diagnosing osteoporosis.
New recommendations for the conduct of economic evaluations in osteoporosis
An expert working group has established recommendations for the design and conduct of economic evaluations in osteoporosis, as well as guidance for reporting these evaluations.
From receptor structure to new osteoporosis drugs
Researchers at the University of Zurich have determined the three-dimensional structure of a receptor that controls the release of calcium from bones.
How a Mediterranean diet could reduce osteoporosis
Eating a Mediterranean-type diet could reduce bone loss in people with osteoporosis -- according to new research from the University of East Anglia.
Osteoporosis drug may benefit heart health
The osteoporosis drug alendronate was linked with a reduced risk of cardiovascular death, heart attack, and stroke in a Journal of Bone and Mineral Research study of patients with hip fractures.
New treatment for osteoporosis provides better protection against fractures
A new treatment for osteoporosis provides major improvements in bone density and more effective protection against fractures than the current standard treatment.
More Osteoporosis News and Osteoporosis Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Rethinking Anger
Anger is universal and complex: it can be quiet, festering, justified, vengeful, and destructive. This hour, TED speakers explore the many sides of anger, why we need it, and who's allowed to feel it. Guests include psychologists Ryan Martin and Russell Kolts, writer Soraya Chemaly, former talk radio host Lisa Fritsch, and business professor Dan Moshavi.
Now Playing: Science for the People

#538 Nobels and Astrophysics
This week we start with this year's physics Nobel Prize awarded to Jim Peebles, Michel Mayor, and Didier Queloz and finish with a discussion of the Nobel Prizes as a way to award and highlight important science. Are they still relevant? When science breakthroughs are built on the backs of hundreds -- and sometimes thousands -- of people's hard work, how do you pick just three to highlight? Join host Rachelle Saunders and astrophysicist, author, and science communicator Ethan Siegel for their chat about astrophysics and Nobel Prizes.